EPIC Pharmacy Team Delivers the State of Specialty Drug Spend
Specialty Spend Is on the Rise Again EPIC recently unpacked everything you need to know about the state of specialty, with a specific focus on biosimilar and specialty generics. We continue to see double-digit increases in per member per year cost for specialty drugs, and nearly 40% of that spend occurs in the medical benefit. Rigorous management across both benefits is critical to managing overall specialty spend. This webinar uncovered what is driving increased spend and what you can do about it. Agenda: Deeper dive into specialty spend and what you can do about it Emerging trends in biosimilar âŠ
https://www.epicbrokers.com/insights/epic-pharmacy-team-delivers-specialty-drug-trends/